We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights ASML, Alibaba, Intuitive Surgical, Paul Mueller and Presurance
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 10, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ASML Holding N.V. (ASML - Free Report) , Alibaba Group Holding Ltd. (BABA - Free Report) , Intuitive Surgical, Inc. (ISRG - Free Report) , Paul Mueller Co. (MUEL - Free Report) and Presurance Holdings, Inc. (PRHI - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for ASML, Alibaba and Intuitive Surgical
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ASML Holding N.V., Alibaba Group Holding Ltd., Intuitive Surgical, Inc. as well as two micro-cap stocks, Paul Mueller Co. and Presurance Holdings, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
ASML’s shares have outperformed the Zacks Semiconductor Equipment - Wafer Fabrication industry over the past year (+37.2% vs. +35.3%). Per the Zacks analyst, the company benefits from strong AI-driven demand for advanced Logic and Memory capacity, rising lithography intensity and sustained demand for EUV, DUV and installed-base services. High-NA adoption further strengthens its technology leadership, while higher volumes, upgrades and improved product mix support profitability.
However, growth depends on sustained customer capital spending and successful production expansion. Export-control uncertainty surrounding China remains a risk, while the timing of broader High-NA adoption is still uncertain.
Alibaba’s shares have underperformed the Internet - Commerce industry over the last six months (-20.2% vs. -4.4%). The Zacks analyst believes that the company faces elevated investment requirements, slower China commerce monetization and continued spending on quick commerce and AI development. Heavy infrastructure outlays and uneven core-commerce trends constrain near-term returns.
Yet, its broad commerce ecosystem, growing AI-driven cloud demand and deeper consumer-platform integration offer attractive long-term growth opportunities. Better operating discipline and expanding AI applications further strengthen its prospects.
Intuitive Surgical’s shares have underperformed the Medical - Instruments industry over the past year (-21.4% vs. +3.1%). The Zacks analyst believes that the company faces moderating U.S. procedure growth, weak bariatric volumes and intensifying competition and pricing pressures in China. Tariffs, product mix, hospital budget constraints and extended-use instruments could also weigh on margins and revenue growth.
However, its broad robotic platform, expanding installed base and recurring revenue model support durable growth. Adoption of Da Vinci 5, SP and Ion systems, healthy procedure demand and digital innovation strengthen its long-term prospects.
Paul Mueller’s shares have outperformed the Zacks Manufacturing - General Industrial industry over the past two years (+120.1% vs. -3.5%). The Zacks analyst believes that the company benefits from a sizable Industrial Equipment backlog, sustained demand and improving international contributions. Capacity expansion, modest leverage and continued shareholder returns further strengthen its investment case.
Yet, project mix, labor efficiency, contractor reliance and delivery schedules create execution risks. Rising working-capital needs, weaker cash conversion and exposure to dairy regulations and currency movements could constrain margin recovery.
Presurance’s shares have outperformed the Zacks Insurance - Multi Line industry over the last six months (+53.0% vs. +10.3%). The Zacks analyst believes that the company benefited from improved underwriting discipline and stronger profitability. Its strategic shift toward personal insurance and improved claims management have supported better operating performance, while strengthened capital resources have also aided.
However, the company’s business has contracted as it exits legacy commercial insurance lines, reducing premium volume. Cash outflows, regulatory capital constraints and a smaller operating scale remain concerns.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
The Zacks Analyst Blog Highlights ASML, Alibaba, Intuitive Surgical, Paul Mueller and Presurance
For Immediate Release
Chicago, IL – November 10, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ASML Holding N.V. (ASML - Free Report) , Alibaba Group Holding Ltd. (BABA - Free Report) , Intuitive Surgical, Inc. (ISRG - Free Report) , Paul Mueller Co. (MUEL - Free Report) and Presurance Holdings, Inc. (PRHI - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for ASML, Alibaba and Intuitive Surgical
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ASML Holding N.V., Alibaba Group Holding Ltd., Intuitive Surgical, Inc. as well as two micro-cap stocks, Paul Mueller Co. and Presurance Holdings, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Today's Featured Research Reports
ASML’s shares have outperformed the Zacks Semiconductor Equipment - Wafer Fabrication industry over the past year (+37.2% vs. +35.3%). Per the Zacks analyst, the company benefits from strong AI-driven demand for advanced Logic and Memory capacity, rising lithography intensity and sustained demand for EUV, DUV and installed-base services. High-NA adoption further strengthens its technology leadership, while higher volumes, upgrades and improved product mix support profitability.
However, growth depends on sustained customer capital spending and successful production expansion. Export-control uncertainty surrounding China remains a risk, while the timing of broader High-NA adoption is still uncertain.
(You can read the full research report on ASML here >>>)
Alibaba’s shares have underperformed the Internet - Commerce industry over the last six months (-20.2% vs. -4.4%). The Zacks analyst believes that the company faces elevated investment requirements, slower China commerce monetization and continued spending on quick commerce and AI development. Heavy infrastructure outlays and uneven core-commerce trends constrain near-term returns.
Yet, its broad commerce ecosystem, growing AI-driven cloud demand and deeper consumer-platform integration offer attractive long-term growth opportunities. Better operating discipline and expanding AI applications further strengthen its prospects.
(You can read the full research report on Alibaba here >>>)
Intuitive Surgical’s shares have underperformed the Medical - Instruments industry over the past year (-21.4% vs. +3.1%). The Zacks analyst believes that the company faces moderating U.S. procedure growth, weak bariatric volumes and intensifying competition and pricing pressures in China. Tariffs, product mix, hospital budget constraints and extended-use instruments could also weigh on margins and revenue growth.
However, its broad robotic platform, expanding installed base and recurring revenue model support durable growth. Adoption of Da Vinci 5, SP and Ion systems, healthy procedure demand and digital innovation strengthen its long-term prospects.
(You can read the full research report on Intuitive Surgical here >>>)
Paul Mueller’s shares have outperformed the Zacks Manufacturing - General Industrial industry over the past two years (+120.1% vs. -3.5%). The Zacks analyst believes that the company benefits from a sizable Industrial Equipment backlog, sustained demand and improving international contributions. Capacity expansion, modest leverage and continued shareholder returns further strengthen its investment case.
Yet, project mix, labor efficiency, contractor reliance and delivery schedules create execution risks. Rising working-capital needs, weaker cash conversion and exposure to dairy regulations and currency movements could constrain margin recovery.
(You can read the full research report on Paul Mueller here >>>)
Presurance’s shares have outperformed the Zacks Insurance - Multi Line industry over the last six months (+53.0% vs. +10.3%). The Zacks analyst believes that the company benefited from improved underwriting discipline and stronger profitability. Its strategic shift toward personal insurance and improved claims management have supported better operating performance, while strengthened capital resources have also aided.
However, the company’s business has contracted as it exits legacy commercial insurance lines, reducing premium volume. Cash outflows, regulatory capital constraints and a smaller operating scale remain concerns.
(You can read the full research report on Presurance here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.